{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:00:19Z","timestamp":1780567219499,"version":"3.54.1"},"reference-count":12,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,11,25]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>We report a novel case of a patient who presented with new diagnoses of both cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCAs) positive vasculitis and chronic lymphocytic leukaemia (CLL). The patient was a 79-year-old man who presented with melena, haemoptysis, acute hypoxia and acute kidney injury. In the current literature, there are rare associations of c-ANCA vasculitis and malignancy, but very few, if any, relating c-ANCA vasculitis and CLL. This case is unique due to the presence of both pathologies and an uncommon presentation of the vasculitis. He presented with renal and pulmonary findings, unlike the dermal manifestations commonly seen with vasculitis. We think that this could be an easily overlooked combination of diseases and, therefore, the purpose of this case is to prevent delays in care that could affect patient outcomes and also to encourage further research into the relationship between these diseases.<\/jats:p>","DOI":"10.1136\/bcr-2020-238371","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T18:18:21Z","timestamp":1608661101000},"page":"e238371","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between vasculitis and chronic lymphocytic leukaemia: a correlation without causation"],"prefix":"10.1136","volume":"13","author":[{"given":"David Charles","family":"Henderson","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Michigan State University College of Human Medicine, East Lansing, Michigan, USA"},{"name":"Family Medicine, Mercy Health Saint Mary's, Grand Rapids, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Barringer","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Michigan State University College of Human Medicine, East Lansing, Michigan, USA"},{"name":"Mercy Health St. Mary's Family Medicine Residency, Trinity Health, Grand Rapids, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"2025082701582853000_13.12.e238371.1","first-page":"1615","article-title":"Anca-Associated small-vessel vasculitis","volume":"65","author":"Mansi","year":"2002","journal-title":"Am Fam Physician"},{"key":"2025082701582853000_13.12.e238371.2","first-page":"731","article-title":"Leukemia: an overview for primary care","volume":"89","author":"Davis","year":"2014","journal-title":"Am Fam Physician"},{"key":"2025082701582853000_13.12.e238371.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2012.12.003"},{"key":"2025082701582853000_13.12.e238371.4","unstructured":"Janeway CA , Travers P , Walport M , et al . Immunobiology: the immune system in health and disease. 5th edn. New York: Garland Science, 2001."},{"key":"2025082701582853000_13.12.e238371.5","first-page":"556","article-title":"Systemic vasculitis","volume":"83","author":"Sharma","year":"2011","journal-title":"Am Fam Physician"},{"key":"2025082701582853000_13.12.e238371.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1732175","article-title":"Anca-Associated vasculitides and hematologic malignancies: lessons from the past and future perspectives","volume":"2019","author":"Folci","year":"2019","journal-title":"J Immunol Res"},{"key":"2025082701582853000_13.12.e238371.7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3731"},{"key":"2025082701582853000_13.12.e238371.8","first-page":"828","article-title":"Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders","volume":"8","author":"Duek","year":"2006","journal-title":"The Israel Medical Association Journal"},{"key":"2025082701582853000_13.12.e238371.9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1189\/jlb.69.2.177","article-title":"Proteinase 3, Wegener's autoantigen: from gene to antigen","volume":"69","author":"van der Geld","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2025082701582853000_13.12.e238371.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh374"},{"key":"2025082701582853000_13.12.e238371.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.23085"},{"key":"2025082701582853000_13.12.e238371.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.08.017"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:58:37Z","timestamp":1756285117000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":12,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,22]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/bcr-2020-238371"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238371","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}